From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and equality more than ever over the last few years.
Amgen has chalked up a victory in a patent infringement lawsuit with Regeneron over blockbuster ophthalmic drug Eylea and decided to launch its biosimilar in the US – even though the legal